Osteoporosis Treatment

Treatment

Surgical Intervention

Eg vertebroplasty, kyphoplasty
Management of osteoporotic fractures should involve both non-pharmacological and pharmacological treatment of osteoporosis, management of pain, and surgery only if necessary
Considered when treatment of acute symptomatic vertebral fractures are nonresponsive to conservative treatments
- Not to be considered as 1st-line treatment of vertebral fractures due to increased risk of fractures in adjacent vertebrae
Several studies have shown improvement in back pain after treatment with vertebroplasty cement augmentation
Kyphoplasty may partially reverse vertebral deformities and provide relief from pain

Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes

Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Navigating the CPP patient journey – case-based discussion for nurses

06 May 2021

In a webinar held on 27 March 2021, paediatric endocrinology nurses Karen Blair, Kate Davies, and Siti Zarina Yaakop shared insights and clinical experience based on their frontline roles in caring for patients with central precocious puberty (CPP) and supporting their family members.

NCDs continue with march in the shadow of COVID-19

Pank Jit Sin, 02 Sep 2020

The most recent report by the National Health and Morbidity Survey (NHMS) 2019 proved to be a blow to public health in Malaysia. Even with consistent, unrelenting efforts by stakeholders and policymakers, the figures for NCDs continue to climb. MIMS Doctor reached out to the Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah to get up to date with the COVID-19 situation in the country and to obtain his thoughts on the ramifications of the findings.